Your browser doesn't support javascript.
loading
Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells.
Du, Li-Jun; Feng, Yu-Xiang; He, Zhi-Xing; Huang, Lin; Wang, Qiao; Wen, Cheng-Ping; Zhang, Yun.
Afiliación
  • Du LJ; Institute of Basic Research in Clinical Medicine, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
  • Feng YX; Institute of Basic Research in Clinical Medicine, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
  • He ZX; Institute of Basic Research in Clinical Medicine, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
  • Huang L; Institute of Basic Research in Clinical Medicine, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
  • Wang Q; Institute of Basic Research in Clinical Medicine, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
  • Wen CP; Institute of Basic Research in Clinical Medicine, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China. chengpw2010@126.com.
  • Zhang Y; Institute of Basic Research in Clinical Medicine, College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, China. zhangyun@zcmu.edu.cn.
Acta Pharmacol Sin ; 43(6): 1521-1533, 2022 Jun.
Article en En | MEDLINE | ID: mdl-34552214

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Interleucina-17 / Lupus Eritematoso Sistémico Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Interleucina-17 / Lupus Eritematoso Sistémico Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China